Growth Metrics

GoodRx Holdings (GDRX) Equity Ratio (2019 - 2026)

GoodRx Holdings' Equity Ratio history spans 7 years, with the latest figure at 0.44 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 15.93% to 0.44 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.44, a 15.93% decrease, with the full-year FY2025 number at 0.44, down 15.93% from a year prior.
  • Equity Ratio hit 0.44 in Q4 2025 for GoodRx Holdings, down from 0.45 in the prior quarter.
  • Over the last five years, Equity Ratio for GDRX hit a ceiling of 0.53 in Q2 2023 and a floor of 0.43 in Q1 2024.
  • Historically, Equity Ratio has averaged 0.5 across 5 years, with a median of 0.51 in 2022.
  • The widest YoY moves for Equity Ratio: up 16.39% in 2025, down 15.93% in 2025.
  • Tracing GDRX's Equity Ratio over 5 years: stood at 0.52 in 2021, then fell by 1.84% to 0.51 in 2022, then decreased by 5.56% to 0.48 in 2023, then increased by 8.86% to 0.52 in 2024, then fell by 15.93% to 0.44 in 2025.
  • Business Quant data shows Equity Ratio for GDRX at 0.44 in Q4 2025, 0.45 in Q3 2025, and 0.49 in Q2 2025.